Previous close | 210.05 |
Open | 209.48 |
Bid | 204.05 x 800 |
Ask | 209.42 x 800 |
Day's range | 208.40 - 211.40 |
52-week range | 180.93 - 348.67 |
Volume | |
Avg. volume | 333,590 |
Market cap | 8.077B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 90.34 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
Penumbra Inc (NYSE:PEN), a global healthcare company focused on innovative therapies, has seen a recent insider transaction according to the latest SEC filings.
It is hard to get excited after looking at Penumbra's (NYSE:PEN) recent performance, when its stock has declined 13...